A citation-based method for searching scientific literature

David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl, Maximilian von Eynatten. Circulation 2014
Times Cited: 783



Hiddo J L Heerspink, Mikhail Kosiborod, Silvio E Inzucchi, David Z I Cherney. Kidney Int 2018
Times Cited: 149




List of shared articles



Times cited



Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease.
Clifford J Bailey, Caroline Day, Srikanth Bellary. Curr Diab Rep 2022
1

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Luca Rinaldi, Anna Di Martino, Gaetana Albanese, Jessica Di Salvo, Raffaella Epifani, Raffaele Marfella, Giovanni Docimo,[...]. Int J Mol Sci 2022
0

SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives.
Alexia Piperidou, Charalampos Loutradis, Pantelis Sarafidis. J Hum Hypertens 2021
7

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Am J Kidney Dis 2021
37

Chronic kidney disease in patients with diabetes mellitus.
Espen Nordheim, Trond Geir Jenssen. Endocr Connect 2021
0

Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease.
Mohanad Almaimani, Vikas S Sridhar, David Z I Cherney. Curr Opin Nephrol Hypertens 2021
1